XML 60 R48.htm IDEA: XBRL DOCUMENT v3.23.3
Related Parties Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jul. 27, 2021
Jul. 01, 2020
Jun. 16, 2022
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Mar. 31, 2023
Dec. 01, 2021
Sep. 30, 2021
Sep. 07, 2021
Related Parties Transactions (Details) [Line Items]                          
Loans bear interest rate     5.00%                    
Additional working capital percentage     6.40%                    
Conversion price, description             The Company may convert the Note at any time into shares of Rgene’s common stock at either (i) a fixed conversion price equal to $1.00 per share or (ii) 20% discount of the stock price of the then most recent offering, whichever is lower; the conversion price is subject to adjustment as set forth in the Note. The Note includes standard events of default, as well as a cross default provision pursuant to which a breach of the Service Agreement will trigger an event of default under the convertible note if not cured after 5 business days of written notice regarding the breach is provided.            
Balance of outstanding loans             $ 500,000            
Accrued interest             32,518   $ 13,819        
Other receivables       $ 624,373     624,373   757,343        
Loan agreement amount                 507,000        
Outstanding balance amount             $ 315,947   188,753        
Interest rate       6.50%     6.50%            
Due from BHK             $ 107,615   112,822        
Interest expenses       $ 9,327 $ 0   24,400 $ 0          
Outstanding principal and accrued interest       144,460     144,460   151,450        
Interest expenses       $ 5,015 $ 5,208   $ 15,082 15,922          
Bear Interest Rate [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Loan agreement, description             The advances bear interest rate of 12% per annum.            
BioFirst (Australia) [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Accrued interest             $ 681,185            
R&D cost   $ 361,487                      
Interest rate percentage                     6.50% 6.50%  
Loan agreement amount                     $ 250,000   $ 67,873
Repaid loan $ 249,975                        
Research fee                 660,484        
Accrued interest             141,596   92,171        
JIANGS [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Interest expenses             $ 499 $ 0          
JIANGS [Member] | Minimum [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Loans bear interest rate       0.00%     0.00%            
JIANGS [Member] | Maximum [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Loans bear interest rate       1.00%     1.00%            
Convertible Debt [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Principal amount     $ 1,000,000                    
BioFirst [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Maturity date                     Nov. 30, 2022    
Loan agreement, description             The advances bear interest 1% per month (or equivalent to 12% per annum).            
Several Loan Agreements [Member] | AUSTRALIA                          
Related Parties Transactions (Details) [Line Items]                          
Loan agreement amount                   $ 88,091      
Outstanding balance amount           $ 25,500              
Related Party [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Other receivables       $ 2,528     $ 2,528   0        
BHK Co Development Agreement [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Loan agreement, description             The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.            
JIANGS [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Outstanding balance amount             $ 19,789   $ 19,789